| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1600-0404.2006.00670.X |
| P8608 | Fatcat ID | release_uqiar3h6yzalbodtgfkkz3kf2m |
| P698 | PubMed publication ID | 16867028 |
| P2093 | author name string | Linde M | |
| P2860 | cites work | Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks | Q28171147 |
| Zolmitriptan versus a combination of acetylsalicylic acid and metoclopramide in the acute oral treatment of migraine: a double-blind, randomised, three-attack study | Q28192365 | ||
| Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison | Q28201298 | ||
| The premonitory symptoms (prodrome): a tertiary care study of 893 migraineurs | Q28284647 | ||
| Physical treatments for headache: a structured review | Q30855017 | ||
| Prevalence and burden of migraine in the United States: data from the American Migraine Study II. | Q31974113 | ||
| Astroglia and glutamate in physiology and pathology: aspects on glutamate transport, glutamate-induced cell swelling and gap-junction communication | Q33919382 | ||
| The diagnostic value of historical features in primary headache syndromes: a comprehensive review | Q33920861 | ||
| Efficacy of gabapentin in migraine prophylaxis | Q33938297 | ||
| Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial | Q34167309 | ||
| Gastric motor effects of triptans: open questions and future perspectives. | Q34278893 | ||
| Brain stem activation in spontaneous human migraine attacks | Q34297421 | ||
| Petasites hybridus root (butterbur) is an effective preventive treatment for migraine | Q34380322 | ||
| Calcitonin gene-related peptide (CGRP) and the pathophysiology of headache: therapeutic implications. | Q34401698 | ||
| Acupuncture for patients with migraine: a randomized controlled trial | Q34415925 | ||
| Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial | Q34458351 | ||
| Efficacy and tolerability of prochlorperazine buccal tablets in treatment of acute migraine | Q34528287 | ||
| Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials | Q34647375 | ||
| Migraine prophylaxis. A comparison of propranolol and amitriptyline | Q34690864 | ||
| Improving patient compliance to prophylactic migraine therapy | Q34760008 | ||
| Electrophysiological Studies in Migraine: A Comprehensive Review of Their Interest and Limitations | Q35109140 | ||
| Ethical aspects of placebo in migraine research | Q35209630 | ||
| Influence of sumatriptan on gastric fundus tone and on the perception of gastric distension in man | Q35359719 | ||
| Contemporary concepts of migraine pathogenesis | Q35569299 | ||
| Therapeutic implications of central and peripheral neurologic mechanisms in migraine | Q35569301 | ||
| Recent findings in headache genetics | Q35786716 | ||
| Migraine aura: new information on underlying mechanisms | Q35786719 | ||
| Propranolol in the management of recurrent migraine: a meta-analytic review. | Q37096564 | ||
| Subcutaneous sumatriptan provides symptomatic relief at any pain intensity or time during the migraine attack | Q39356297 | ||
| The effects of exercise and exercise-related changes in blood nitric oxide level on migraine headache | Q39390568 | ||
| Sumatriptan plus metoclopramide in triptan-nonresponsive migraineurs | Q39392149 | ||
| Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine | Q39400440 | ||
| The efficacy of metoclopramide in the treatment of migraine headache | Q39411865 | ||
| The doctor and the migraine patient: improving compliance | Q39457545 | ||
| One-year prevalence of migraine in Sweden: a population-based study in adults | Q39578180 | ||
| Behavioral and prophylactic pharmacological intervention studies of pediatric migraine: an exploratory meta-analysis | Q40435406 | ||
| Migraine can be induced by sildenafil without changes in middle cerebral artery diameter | Q40616175 | ||
| Familial occurrence of headache | Q40778964 | ||
| Visual system dysfunction in migraine: a review of clinical and psychophysical findings | Q40919082 | ||
| Psychological treatments for migraine | Q40959299 | ||
| A nationwide survey of migraine in France: prevalence and clinical features in adults. GRIM | Q41823868 | ||
| Migraine prophylactic medication usage patterns in The Netherlands | Q43415925 | ||
| Timing and topography of cerebral blood flow, aura, and headache during migraine attacks | Q43706641 | ||
| Magnetic resonance angiography in facial and other pain: neurovascular mechanisms of trigeminal sensation | Q43764929 | ||
| Contrasts in cortical magnesium, phospholipid and energy metabolism between migraine syndromes | Q43968842 | ||
| Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160 mg daily | Q44016434 | ||
| A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis | Q44023099 | ||
| Acupuncture in the prophylactic treatment of migraine without aura: a comparison with flunarizine | Q44187257 | ||
| Impact of antimigraine compounds on cognitive processing: a placebo-controlled crossover study | Q44663011 | ||
| Population-based door-to-door survey of migraine in Japan: the Daisen study | Q44773861 | ||
| Topiramate for migraine prevention: a randomized controlled trial | Q44776025 | ||
| Aerobic exercise and plasma beta endorphin levels in patients with migrainous headache without aura | Q44776567 | ||
| Topiramate in migraine prophylaxis--results from a placebo-controlled trial with propranolol as an active control | Q45022357 | ||
| No effect of eletriptan administration during the aura phase of migraine | Q45094141 | ||
| Focal headache during balloon inflation in the internal carotid and middle cerebral arteries | Q45131574 | ||
| Sumatriptan (5-HT1B/1D-agonist) causes a transient allodynia | Q45164398 | ||
| Topiramate in migraine prophylaxis: a randomised double-blind versus placebo study. | Q45205475 | ||
| Zolmitriptan nasal spray provides fast relief of migraine symptoms and is preferred by patients: a Swedish study of preference in clinical practice | Q47111290 | ||
| Impairment of parasympathetic baroreflex responses in migraine patients | Q47867393 | ||
| Premonitory symptoms in migraine: an electronic diary study | Q48015914 | ||
| 5-Hydroxytryptamine and glutamate modulate velocity and extent of intercellular calcium signalling in hippocampal astroglial cells in primary cultures | Q48205718 | ||
| Migraine history and migraine-induced stroke in the Dijon stroke registry | Q48280888 | ||
| Retinal plasma extravasation in animals but not in humans: implications for the pathophysiology of migraine | Q48423342 | ||
| Cognitive disturbances and regional cerebral blood flow abnormalities in migraine patients: their relationship with the clinical manifestations of the illness. | Q48559164 | ||
| Effectiveness of multidisciplinary intervention in the treatment of migraine: a randomized clinical trial | Q48572094 | ||
| Migraine Postdromes: Symptoms After Attacks | Q48631621 | ||
| Reversible cognitive decline accompanies migraine and cluster headaches | Q48714786 | ||
| Regulation of regional cerebral blood flow during and between migraine attacks | Q48720461 | ||
| Migraine patients experience poorer subjective well-being/quality of life even between attacks | Q48825421 | ||
| Balance disorders in headache patients: evaluation by computerized static stabilometry | Q48899446 | ||
| Role of the needling per se in acupuncture as prophylaxis for menstrually related migraine: a randomized placebo-controlled study. | Q51565092 | ||
| The impact of migraine on quality of life in the general population: the GEM study. | Q51974172 | ||
| Clinical characteristics of 362 patients with familial migraine with aura. | Q53288456 | ||
| Attitudes and burden of disease among self-considered migraineurs--a nation-wide population-based survey in Sweden. | Q53289309 | ||
| Self-awareness of migraine: interpreting the labels that headache sufferers apply to their headaches. | Q53314870 | ||
| Quality of life differs among headache diagnoses: analysis of SF-36 survey in 901 headache patients. | Q53500187 | ||
| A positron emission tomographic study in spontaneous migraine. | Q53574528 | ||
| Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. | Q55040377 | ||
| Methysergide. | Q55068091 | ||
| Subcutaneous sumatriptan during the migraine aura | Q57025045 | ||
| Some clinical features of the acute migraine attack. An analysis of 750 patients | Q57025467 | ||
| Interictal and Postictal Cognitive Changes in Migraine | Q57515573 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 71-83 | |
| P577 | publication date | 2006-08-01 | |
| P1433 | published in | Acta Neurologica Scandinavica | Q4676732 |
| P1476 | title | Migraine: a review and future directions for treatment | |
| P478 | volume | 114 |
| Q43545775 | "It's a balance between letting it influence life completely and not letting it influence life at all"--a qualitative study of migraine prevention from patients' perspective. |
| Q37425639 | Calcitonin gene-related peptide receptor antagonists for the treatment of migraine |
| Q24681601 | Cellular mechanisms underlying the pharmacological induction of phosphenes |
| Q36012931 | Chiropractic management of essential tremor and migraine: a case report |
| Q48765812 | EuroQol (EQ-5D) health utility scores for patients with migraine |
| Q84979035 | Migraine general aspects |
| Q61982605 | Migraine genetics and prospects for pharmacotherapy |
| Q45004675 | Pain, mindfulness, and spirituality: A randomized controlled trial comparing effects of mindfulness and relaxation on pain-related outcomes in migraineurs |
| Q36239483 | The acute and preventative treatment of episodic migraine |
Search more.